| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.25B | 221.75B | 187.79B | 153.67B | 148.07B | 140.03B |
| Gross Profit | 39.21B | 36.71B | 30.88B | 25.85B | 23.66B | 20.89B |
| EBITDA | 15.27B | 14.36B | 10.28B | 7.75B | 7.64B | 6.61B |
| Net Income | 9.91B | 8.84B | 7.46B | 6.32B | 5.36B | 4.75B |
Balance Sheet | ||||||
| Total Assets | 172.98B | 171.37B | 193.79B | 152.53B | 132.24B | 119.96B |
| Cash, Cash Equivalents and Short-Term Investments | 50.47B | 35.96B | 32.03B | 34.53B | 28.42B | 33.30B |
| Total Debt | 7.03B | 2.42B | 7.34B | 5.88B | 7.51B | 7.80B |
| Total Liabilities | 85.27B | 91.52B | 120.35B | 88.88B | 73.51B | 66.11B |
| Stockholders Equity | 87.56B | 79.77B | 73.40B | 63.60B | 58.68B | 53.82B |
Cash Flow | ||||||
| Free Cash Flow | 14.36B | 11.19B | -2.35B | 8.44B | -3.64B | 10.87B |
| Operating Cash Flow | 14.65B | 11.59B | -1.71B | 8.94B | -3.43B | 11.14B |
| Investing Cash Flow | -542.00M | -1.29B | -478.00M | 660.00M | -409.00M | -1.54B |
| Financing Cash Flow | 573.00M | -7.69B | -860.00M | -4.57B | -1.74B | -1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥86.48B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
81 Outperform | ¥250.52B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
80 Outperform | ¥126.31B | 8.87 | ― | 3.61% | 0.44% | 26.19% | |
78 Outperform | ¥113.25B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
76 Outperform | ¥107.83B | 7.21 | ― | 3.17% | 8.25% | 2.10% | |
70 Outperform | ¥125.45B | 12.83 | ― | 3.47% | 3.93% | 68.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |